Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
- The primary objective of this trial is to assess the safety and feasibility of 5-FU when
given concurrently with5 Gy x 5 fractions IMRT.
- The secondary endpoint is to assess disease local control and the response rate after
short course radiotherapy concurrent with dose escalation infusion 5-fu followed by
mFOLFOX and delayed surgery.